Search

everythinglearnresearchcommunity

for

Search:↓

Polycystic Ovary Syndrome is common but often undiagnosed, and early treatment is important to prevent health problems.

Androgens significantly affect female hair loss, and hormonal treatments may help.

Insulin resistance is significantly linked to a higher risk of depression in women with PCOS.

Natural 5α-reduced glucocorticoids might be anti-inflammatory with fewer side effects than current options.

The research found that polycystic ovary syndrome (PCOS) has two distinct types, with one having more severe hormone and insulin issues.

Excessive hair growth can be assessed by history, exam, and blood tests, and treated with medication like dexamethasone, birth control pills, and spironolactone.

Blocking the prolactin receptor might help treat various diseases, but more research is needed.

Low-dose flutamide helps reduce excessive hair growth and is even more effective with birth control, without bad effects on blood fats.

The document concludes that managing non-classical congenital adrenal hyperplasia in females requires personalized treatment, genetic counseling, and a team of specialists.

Young women with high male hormone levels or PCOS often feel more psychological distress and have a lower quality of life.

With careful management, people with congenital adrenal hyperplasia can have successful pregnancies and become parents.

Testosterone replacement may help post-menopausal women with androgen insufficiency, but more research is needed on its benefits and risks.

New compounds may soon be tested to treat excessive hair growth in women.

The document says that understanding the causes of PCOS is important for treatment, especially in distinguishing the syndrome from just having cystic ovaries, and that losing weight is key for obese women with PCOS.

A teenage girl with high androgen levels and PCOS developed a rare liver tumor, suggesting a possible link between high androgens and the tumor's growth.

Cyclodextrins improve how steroid drugs work and are used in marketed medications and environmental applications.

FPHL causes hair loss in women due to genetics and hormones; minoxidil and anti-androgens are treatments, and early intervention is advised.

Women with hyperandrogenic amenorrhea have similar bone density to healthy women but lower than androgenized women without amenorrhea, and high DHEAS levels might affect bone density.

Greek women with PCOS have a higher risk of metabolic syndrome and are more likely to be overweight compared to healthy controls.

Higher hs-CRP levels in Indian adolescent women with PCOS are more related to BMI than PCOS itself.

Increased HSD11B1 enzyme expression is linked to higher body fat and insulin resistance.

Treating excessive hair in women requires a holistic approach, including medical, aesthetic, and emotional support.

The conclusion is that young women with excessive hair growth should be quickly tested for hormonal issues and treated to improve their social well-being.

Women with nonclassic congenital adrenal hyperplasia experience more sexual dysfunction and distress.

Female mice with disrupted 5α-reductase 1 had significant metabolic issues, including stress response problems, insulin resistance, liver fat buildup, and obesity.

Young women with nonclassic congenital adrenal hyperplasia may experience worse sexual function and mild depression compared to healthy women.

Irregular menstrual cycles in exercising women may be linked to energy deficiency or hormonal imbalances, requiring careful diagnosis for proper treatment.

A woman's masculine symptoms were caused by an ovarian tumor, which improved after surgery.

The article explains how to identify and treat excessive hair growth in women, which can be distressing and may signal other health problems.

Don't combine abiraterone and spironolactone for prostate cancer treatment as it may worsen the disease.